City

Houston (2)

Ann Arbor (1)

Atlanta (1)

Rochester (1)

Overall Status

Recruiting (3)

Terminated (1)

Phase

phase 2 (2)

early phase 1 (1)

Sponsor

M.D. Anderson Cancer Center (2)

Emory University (1)

Mayo Clinic (1)

Collaborator

Eisai Inc. (1)

Study Documents

Intervention Type

other (3)

procedure (3)

drug (2)

radiation (1)

Funder Type

Other (4)

Study Type

Interventional (3)

Observational (1)

thyroid gland papillary carcinoma

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston

Recruiting

Malignant Thyroid Gland Neoplasm
+6 more

Quality-of-Life Assessment
+3 more

Ann Arbor, Michigan
+1 more

Jan 24, 2023

18F-TFB PET/CT Scan in Differentiated Thyroid Cancer

Recruiting

Differentiated Thyroid Gland Carcinoma
+2 more

Computed Tomography
+3 more

Rochester, Minnesota

Mayo Clinic in Rochester

Jan 4, 2023

Benign Thyroid Gland Tumor, Recurrent Thyroid Gland Carcinoma, Thyroid Gland Follicular Tumor of Uncertain Malignant Potential

Recruiting

Benign Thyroid Gland Neoplasm
+4 more

Quality-of-Life Assessment
Radiofrequency Ablation

Houston, Texas

M D Anderson Cancer Center

Sep 3, 2022

Differentiated Thyroid Gland Carcinoma, Thyroid Gland Follicular Carcinoma, Thyroid Gland Papillary Carcinoma Trial in Atlanta

Terminated

Differentiated Thyroid Gland Carcinoma
+2 more

Lenvatinib

Atlanta, Georgia

Emory University Hospital/Winship Cancer Institute

Jun 25, 2021